Pharmacotherapy The use of currently available drugs is mainly based on their effectiveness in treatment of other hypoglycemic conditions such as insulinoma
Interestingly, exendin-4 is similar in structure and function to GLP-1, but is resistant to degradation by DPP4, allowing exendin-4 to remain in circulation for hours rather than just a few minutes
Over a multi-month protocol with many vials, this adds up
If youre not seeing this kind of news coverage in your regular news sources, you may want to give Medscape a look
However, its mechanism of action differs fundamentally from pharmaceutical GLP-1 receptor agonists like semaglutide and liraglutide
Its important for patients to understand that GLP-1 medications are not a skinny shot, but a tool designed to support metabolic health through long-term weight management